Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67,600 ILa | -4.26% | -3.15% | -6.76% |
Sales 2024 * | 2.72B 1,010B 227B | Sales 2025 * | 3.04B 1,128B 254B | Capitalization | 11.55B 4,283B 964B |
---|---|---|---|---|---|
Net income 2024 * | 449M 166B 37.45B | Net income 2025 * | 549M 204B 45.79B | EV / Sales 2024 * | 3.71 x |
Net cash position 2024 * | 1.46B 540B 121B | Net cash position 2025 * | 2.25B 835B 188B | EV / Sales 2025 * | 3.06 x |
P/E ratio 2024 * |
26.2
x | P/E ratio 2025 * |
20.3
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | -4.26% | ||
1 week | -3.15% | ||
Current month | -4.26% | ||
1 month | -17.86% | ||
3 months | -22.89% | ||
6 months | -5.67% | ||
Current year | -6.76% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30/14/30 |
Darren Rushworth
PSD | President | 56 | 01/17/01 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01/13/01 |
David Kostman
CHM | Chairman | 59 | 01/01/01 |
Dan Falk
BRD | Director/Board Member | 79 | 01/01/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.58% | 17 M€ | +7.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 67,600 | -4.26% | 46,850 |
30/24/30 | 70,610 | -0.01% | 204,965 |
29/24/29 | 70,620 | -0.44% | 84,350 |
28/24/28 | 70,930 | +1.14% | 69,375 |
27/24/27 | 70,130 | +0.47% | 51,252 |
Delayed Quote TEL AVIV STOCK EXCHANGE, June 02, 2024 at 06:19 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.76% | 12.07B | |
+10.52% | 3,085B | |
+8.91% | 85.92B | |
+5.14% | 77.91B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B |
- Stock Market
- Equities
- NICE Stock